Mrna Covid 19 Vaccine
- All
- News
- Videos
-
Covid mRNA Vaccines Contributing To Deaths, Doctors Call For Suspension
- Tuesday December 10, 2024
- World News | Written by Anushree Jonko
Dr. Aseem Malhotra, a British Indian Consultant Cardiologist, has written an open letter to the General Medical Council (GMC) of the UK, stating that the vaccines cause greater harm than benefit.
- www.ndtv.com
-
Chinese Travellers Rushing To Hong Kong For mRNA Covid Vaccines: Report
- Thursday January 12, 2023
- World News | Reuters
Scores of mainland Chinese travellers are rushing to Hong Kong to receive mRNA COVID-19 vaccines, which are not available on the Chinese mainland, as the country grapples with a torrent of infections that have overwhelmed its health system.
- www.ndtv.com
-
Sanofi To Invest 400 Million Euros In A mRNA Vaccines Facility
- Tuesday June 29, 2021
- Business | Reuters
The French drug giant and its British counterpart GlaxoSmithKline surprised investors and customers last year when they announced a one-year delay to the launch of their joint COVID vaccine, based on a more conventional technology.
- www.ndtv.com/business
-
Covid mRNA Vaccines Contributing To Deaths, Doctors Call For Suspension
- Tuesday December 10, 2024
- World News | Written by Anushree Jonko
Dr. Aseem Malhotra, a British Indian Consultant Cardiologist, has written an open letter to the General Medical Council (GMC) of the UK, stating that the vaccines cause greater harm than benefit.
- www.ndtv.com
-
Chinese Travellers Rushing To Hong Kong For mRNA Covid Vaccines: Report
- Thursday January 12, 2023
- World News | Reuters
Scores of mainland Chinese travellers are rushing to Hong Kong to receive mRNA COVID-19 vaccines, which are not available on the Chinese mainland, as the country grapples with a torrent of infections that have overwhelmed its health system.
- www.ndtv.com
-
Sanofi To Invest 400 Million Euros In A mRNA Vaccines Facility
- Tuesday June 29, 2021
- Business | Reuters
The French drug giant and its British counterpart GlaxoSmithKline surprised investors and customers last year when they announced a one-year delay to the launch of their joint COVID vaccine, based on a more conventional technology.
- www.ndtv.com/business